These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25495408)

  • 1. CYP2D6 genetic polymorphisms in Southern Mexican Mayan Lacandones and Mestizos from Chiapas.
    López-López M; Peñas-Lledó E; Dorado P; Ortega A; Corona T; Ochoa A; Yescas P; Alonso E; LLerena A
    Pharmacogenomics; 2014; 15(15):1859-65. PubMed ID: 25495408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP2D6 gene polymorphisms and predicted phenotypes in eight indigenous groups from northwestern Mexico.
    Lazalde-Ramos BP; Martínez-Fierro Mde L; Galaviz-Hernández C; Garza-Veloz I; Naranjo ME; Sosa-Macías M; Llerena A
    Pharmacogenomics; 2014 Feb; 15(3):339-48. PubMed ID: 24533713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP2D6 genotype and phenotype in Amerindians of Tepehuano origin and Mestizos of Durango, Mexico.
    Sosa-Macías M; Elizondo G; Flores-Pérez C; Flores-Pérez J; Bradley-Alvarez F; Alanis-Bañuelos RE; Lares-Asseff I
    J Clin Pharmacol; 2006 May; 46(5):527-36. PubMed ID: 16638736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of CYP2D6 and CYP2C19 polymorphisms associated with poor metabolizer phenotype in five Amerindian groups and western Mestizos from Mexico.
    Salazar-Flores J; Torres-Reyes LA; Martínez-Cortés G; Rubi-Castellanos R; Sosa-Macías M; Muñoz-Valle JF; González-González C; Ramírez A; Román R; Méndez JL; Barrera A; Torres A; Medina R; Rangel-Villalobos H
    Genet Test Mol Biomarkers; 2012 Sep; 16(9):1098-104. PubMed ID: 22913530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of CYP2D6 deletion, multiplication, -1584C-->G, 31G-->A and 2988G-->a gene polymorphisms on dextromethorphan metabolism among Mexican tepehuanos and mestizos.
    Sosa-Macías M; Dorado P; Alanis-Bañuelos RE; Llerena A; Lares-Asseff I
    Pharmacology; 2010; 86(1):30-6. PubMed ID: 20588073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethnic background and CYP2D6 genetic polymorphisms in Costa Ricans.
    Céspedes-Garro C; Jiménez-Arce G; Naranjo ME; Barrantes R; Llerena A;
    Rev Biol Trop; 2014 Dec; 62(4):1659-71. PubMed ID: 25720195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interethnic relationships of CYP2D6 variants in native and Mestizo populations sharing the same ecosystem.
    Perez-Paramo YX; Hernandez-Cabrera F; Dorado P; Llerena A; Muñoz-Jimenez S; Ortiz-Lopez R; Rojas-Martinez A
    Pharmacogenomics; 2015; 16(7):703-12. PubMed ID: 25941923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP2D6 genotype and phenotype determination in a Mexican Mestizo population.
    López M; Guerrero J; Jung-Cook H; Alonso ME
    Eur J Clin Pharmacol; 2005 Nov; 61(10):749-54. PubMed ID: 16249913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP2D6 in Amerindians from Southern Mexico: low variability and higher frequency of functional alleles.
    Perez-Paramo YX; Hernandez-Cabrera F; Rojas-Martinez A; Ortiz-Lopez R
    Drug Metab Pers Ther; 2015 Dec; 30(4):231-8. PubMed ID: 26479352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resequencing, haplotype construction and identification of novel variants of CYP2D6 in Mexican Mestizos.
    Contreras AV; Monge-Cazares T; Alfaro-Ruiz L; Hernandez-Morales S; Miranda-Ortiz H; Carrillo-Sanchez K; Jimenez-Sanchez G; Silva-Zolezzi I
    Pharmacogenomics; 2011 May; 12(5):745-56. PubMed ID: 21391885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variability among Mexican Mestizo and Amerindian populations based on three ABCB1 polymorphisms.
    Favela-Mendoza AF; Rangel-Villalobos H; Fricke-Galindo I; Ortega-Vázquez A; Martínez-Cortés G; López-López M
    Mol Biol Rep; 2018 Dec; 45(6):2525-2533. PubMed ID: 30317428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochrome P4501A1 polymorphisms in the Amerindian and Mestizo populations of Mexico.
    Fragoso JM; Juárez-Cedillo T; Hernández-Pacheco G; Ramírez E; Zuñiga J; Izaguirre R; de la Peña A; Granados J; Vargas-Alarcón G
    Cell Biochem Funct; 2005; 23(3):189-93. PubMed ID: 15376230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the ultrarapid metabolizer genotype of cytochrome P450 2D6 on metoprolol pharmacokinetics and pharmacodynamics.
    Kirchheiner J; Heesch C; Bauer S; Meisel C; Seringer A; Goldammer M; Tzvetkov M; Meineke I; Roots I; Brockmöller J
    Clin Pharmacol Ther; 2004 Oct; 76(4):302-12. PubMed ID: 15470329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450 genetic polymorphisms of Mexican indigenous populations.
    Sosa-Macías M; Llerena A
    Drug Metabol Drug Interact; 2013; 28(4):193-208. PubMed ID: 24145057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interethnic variability of CYP2D6 alleles and of predicted and measured metabolic phenotypes across world populations.
    LLerena A; Naranjo ME; Rodrigues-Soares F; Penas-LLedó EM; Fariñas H; Tarazona-Santos E
    Expert Opin Drug Metab Toxicol; 2014 Nov; 10(11):1569-83. PubMed ID: 25316321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of
    P Sarmiento A; Dorado P; Borbón A; de Andrés F; LLerena A;
    Pharmacogenomics; 2020 Nov; 21(17):1227-1236. PubMed ID: 33124522
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of CYP2D6 genotype on adverse effects during treatment with metoprolol: a prospective clinical study.
    Fux R; Mörike K; Pröhmer AM; Delabar U; Schwab M; Schaeffeler E; Lorenz G; Gleiter CH; Eichelbaum M; Kivistö KT
    Clin Pharmacol Ther; 2005 Oct; 78(4):378-87. PubMed ID: 16198657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of CYP2D6 genotype on the pharmacokinetics, pharmacodynamics, and safety of risperidone in healthy volunteers.
    Novalbos J; López-Rodríguez R; Román M; Gallego-Sandín S; Ochoa D; Abad-Santos F
    J Clin Psychopharmacol; 2010 Oct; 30(5):504-11. PubMed ID: 20814331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low frequency of CYP2D6 poor metabolizers among schizophrenia patients.
    Llerena A; Dorado P; Peñas-Lledó EM; Cáceres MC; De la Rubia A
    Pharmacogenomics J; 2007 Dec; 7(6):408-10. PubMed ID: 17325735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of CYP2D6 polymorphisms on dextromethorphan metabolism in Mexican Americans.
    Casner PR
    J Clin Pharmacol; 2005 Nov; 45(11):1230-5. PubMed ID: 16239355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.